Details for Patent: 11,844,758
✉ Email this page to a colleague
Which drugs does patent 11,844,758 protect, and when does it expire?
Patent 11,844,758 protects VORANIGO and is included in one NDA.
This patent has sixty-five patent family members in thirty-five countries.
Drugs Protected by US Patent 11,844,758
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Servier | VORANIGO | vorasidenib | TABLET;ORAL | 218784-001 | Aug 6, 2024 | RX | Yes | No | 11,844,758 | ⤷ Subscribe | A METHOD OF TREATING A GLIOMA CHARACTERIZED BY AN IDHI MUTATION FOLLOWING SURGERY, WHEREIN THE GLIOMA IS GRADE 2 ASTROCYTOMA OR OLIGODENDROGLIOMA | ⤷ Subscribe | ||||
| Servier | VORANIGO | vorasidenib | TABLET;ORAL | 218784-002 | Aug 6, 2024 | RX | Yes | Yes | 11,844,758 | ⤷ Subscribe | A METHOD OF TREATING A GLIOMA CHARACTERIZED BY AN IDHI MUTATION FOLLOWING SURGERY, WHEREIN THE GLIOMA IS GRADE 2 ASTROCYTOMA OR OLIGODENDROGLIOMA | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,844,758
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 096902 | ⤷ Subscribe | |||
| Australia | 2014289744 | ⤷ Subscribe | |||
| Australia | 2019201179 | ⤷ Subscribe | |||
| Brazil | 112016000561 | ⤷ Subscribe | |||
| Brazil | 122017014843 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
